Combined treatment with sitagliptin and vitamin D in a patient with latent autoimmune diabetes in adults (Q42233629)

19 October 2017

Combined treatment with sitagliptin and vitamin D in a patient with latent autoimmune diabetes in adults (English)

1 reference

19 October 2017

0 references

E Rapti

1

1 reference

19 October 2017

S Karras

2

1 reference

19 October 2017

M Grammatiki

3

1 reference

19 October 2017

A Mousiolis

4

1 reference

19 October 2017

X Tsekmekidou

5

1 reference

19 October 2017

E Potolidis

6

1 reference

19 October 2017

P Zebekakis

7

1 reference

19 October 2017

M Daniilidis

8

1 reference

19 October 2017

K Kotsa

9

1 reference

19 October 2017

language of work or name

1 reference

27 May 2016

1 reference

Endocrinology, diabetes & metabolism case reports

19 October 2017

1 reference

19 October 2017

2016

1 reference

19 October 2017

150136

1 reference

Spontaneous complete remission of type 1 diabetes mellitus in an adult - review and case report

19 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4888610

Saxagliptin improves glycaemic control and C-peptide secretion in latent autoimmune diabetes in adults (LADA).

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4888610

Diabetic ketoacidosis as first presentation of latent autoimmune diabetes in adult

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4888610

Latent autoimmune diabetes of the adult: current knowledge and uncertainty

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4888610

Negativation of type 1 diabetes-associated autoantibodies to glutamic acid decarboxylase and insulin in children treated with oral calcitriol

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4888610

Sitagliptin (MK0431) inhibition of dipeptidyl peptidase IV decreases nonobese diabetic mouse CD4 T-cell migration through incretin-dependent and -independent pathways

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4888610

Beta-cell protection and therapy for latent autoimmune diabetes in adults

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4888610

An association analysis of the HLA gene region in latent autoimmune diabetes in adults.

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4888610

Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4888610

Autoimmune diabetes not requiring insulin at diagnosis (latent autoimmune diabetes of the adult): definition, characterization, and potential prevention

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4888610

Dipeptidyl peptidase 4 inhibitor sitagliptin maintains β-cell function in patients with recent-onset latent autoimmune diabetes in adults: one year prospective study

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4888610

One year remission of type 1 diabetes mellitus in a patient treated with sitagliptin

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4888610

Effects of short-term sitagliptin treatment on immune parameters in healthy individuals, a randomized placebo-controlled study.

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4888610

Addition of exenatide or sitagliptin to insulin in new onset type 1 diabetes: a randomized, open label study.

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4888610

Protective effects of 1-alpha-hydroxyvitamin D3 on residual beta-cell function in patients with adult-onset latent autoimmune diabetes (LADA).

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4888610

1,25-Dihydroxyvitamin D3 protects human pancreatic islets against cytokine-induced apoptosis via down-regulation of the Fas receptor

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4888610

Sitagliptin, a Dipeptidyl Peptidase-IV Inhibitor, Improves Psoriasis

17 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27252860

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Latent autoimmune diabetes in adults: a guide for the perplexed

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27252860

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Vitamin D Deficiency Inhibits Pancreatic Secretion of Insulin

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27252860

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1530/EDM-15-0136

1 reference

19 October 2017

1 reference

19 October 2017

PubMed publication ID

27252860

1 reference